These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 10029385
1. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease. Feagan BG. Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385 [No Abstract] [Full Text] [Related]
2. Mesalamine derivatives in the treatment of Crohn's disease. Harrell LE, Hanauer SB. Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540 [Abstract] [Full Text] [Related]
4. Aminosalicylates for induction of remission or response in Crohn's disease. Lim WC, Hanauer S. Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008870. PubMed ID: 21154400 [Abstract] [Full Text] [Related]
5. Controversies with aminosalicylates in inflammatory bowel disease. Lim WC, Hanauer SB. Rev Gastroenterol Disord; 2004 Dec 08; 4(3):104-17. PubMed ID: 15359211 [Abstract] [Full Text] [Related]
6. Drug insight: aminosalicylates for the treatment of IBD. Nielsen OH, Munck LK. Nat Clin Pract Gastroenterol Hepatol; 2007 Mar 08; 4(3):160-70. PubMed ID: 17339853 [Abstract] [Full Text] [Related]
12. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature]. Neĭman KP, Rumiantsev VG. Eksp Klin Gastroenterol; 2006 Mar 14; (3):56-60. PubMed ID: 17203844 [No Abstract] [Full Text] [Related]
13. [Inflammatory diseases of the intestines]. Felley C, Guyot J, Hess J, Mottet C, Delarive J, Michetti P. Rev Med Suisse; 2006 Jan 18; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962 [Abstract] [Full Text] [Related]
14. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G. Clin Gastroenterol Hepatol; 2003 Mar 18; 1(2):122-8. PubMed ID: 15017504 [Abstract] [Full Text] [Related]
18. [Oral Crohn disease. Apropos of a case]. Lambert F, Reychler H. Rev Stomatol Chir Maxillofac; 1997 Dec 18; 98(5):299-302. PubMed ID: 9471674 [Abstract] [Full Text] [Related]
19. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation]. MMW Fortschr Med; 2009 May 07; 151(19):38-9. PubMed ID: 19827443 [No Abstract] [Full Text] [Related]
20. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission. Sandborn WJ, Feagan BG, Lichtenstein GR. Aliment Pharmacol Ther; 2007 Oct 01; 26(7):987-1003. PubMed ID: 17877506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]